betnovate 0.1% cream
glaxosmithkline uk ltd - betamethasone valerate - cutaneous cream - 1mg/1gram
betnovate c
glaxosmithkline nz limited - betamethasone valerate 0.1%{relative} (0.122% with overage); clioquinol 3%{relative} - topical ointment - active: betamethasone valerate 0.1%{relative} (0.122% with overage) clioquinol 3%{relative} excipient: liquid paraffin white soft paraffin - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.
betamethasone valerate 0.1% cream
a a h pharmaceuticals ltd - betamethasone valerate - cutaneous cream - 1mg/1gram
betamethasone valerate 0.1% cream
kent pharma (uk) ltd - betamethasone valerate - cutaneous cream - 1mg/1gram
betamethasone valerate 0.1% cream
alliance healthcare (distribution) ltd - betamethasone valerate - cutaneous cream - 1mg/1gram
betamethasone valerate 0.1% cream
teva uk ltd - betamethasone valerate - cutaneous cream - 1mg/1gram
betamethasone valerate 0.1% cream
dowelhurst ltd - betamethasone valerate - cutaneous cream - 1mg/1gram
betamethasone valerate 0.1% cream
de pharmaceuticals - betamethasone valerate - cutaneous cream - 1mg/1gram
betamethasone valerate 0.1% cream
sigma pharmaceuticals plc - betamethasone valerate - cutaneous cream - 1mg/1gram
betamethasone valerate 0.1% cream
actavis uk ltd - betamethasone valerate - cutaneous cream - 1mg/1gram